Literature DB >> 3081806

Optimal rate of enteral glucose administration in children with glycogen storage disease type I.

W F Schwenk, M W Haymond.   

Abstract

Rates of administration of enteral carbohydrate to maintain the plasma glucose concentration and suppress organic acidemia in young children with glycogen storage disease Type I have not been clearly established. Therefore, we studied six children with the disease during sequential nasogastric infusions of carbohydrate at four different rates (10.5, 8.6, 5.8, and 3 mg of carbohydrate per kilogram of body weight per minute). The rates at which total and endogenous glucose appeared in the plasma were measured with [2H2] glucose. The infusion rates of carbohydrate were linearly correlated (r = 0.88, P less than 0.001) with the plasma glucose concentration, which was about 90 mg per deciliter at a rate of 8.6 mg per kilogram per minute. The mean (+/- SE) rate of appearance of endogenous glucose was 1.4 +/- 0.1 mg per kilogram per minute at a nasogastric infusion rate of 5.8 mg of carbohydrate per kilogram per minute (a rate similar to that of hepatic glucose production in normal children who have fasted overnight), and was completely suppressed at 10.5 mg of carbohydrate per kilogram per minute. Concentrations of plasma lactate, pyruvate, free fatty acids, and ketone bodies were inversely related to the rate of carbohydrate administration below 8.6 mg per kilogram per minute. We conclude that the minimal nocturnal nasogastric infusion rate of carbohydrate needed to maintain plasma glucose concentrations and minimize organic acidemia in young children with glycogen storage disease Type I is approximately 8 to 9 mg per kilogram per minute.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081806     DOI: 10.1056/NEJM198603133141104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  13 in total

Review 1.  Dietary dilemmas in the management of glycogen storage disease type I.

Authors:  Kaustuv Bhattacharya
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

Review 2.  Techniques for studying hepatic metabolism in vivo.

Authors:  J V Leonard; G N Thompson
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Urinary lactate excretion in type 1 glycogenosis--a marker of metabolic control or renal tubular dysfunction?

Authors:  P J Lee; C Chatterton; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 4.  Hypoglycemia in infancy and childhood.

Authors:  R P Schwartz
Journal:  Indian J Pediatr       Date:  1997 Jan-Feb       Impact factor: 1.967

5.  Glucose production rates in type 1 glycogen storage disease.

Authors:  J E Collins; K Bartlett; J V Leonard; A Aynsley-Green
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

6.  Estimation of glucose carbon recycling in children with glycogen storage disease: A 13C NMR study using [U-13C]glucose.

Authors:  B Kalderon; S H Korman; A Gutman; A Lapidot
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

7.  Inherited disorders of carbohydrate metabolism in children studied by 13C-labelled precursors, NMR and GC-MS.

Authors:  A Lapidot
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

8.  A potential role for muscle in glucose homeostasis: in vivo kinetic studies in glycogen storage disease type 1a and fructose-1,6-bisphosphatase deficiency.

Authors:  Hidde H Huidekoper; Gepke Visser; Mariëtte T Ackermans; Hans P Sauerwein; Frits A Wijburg
Journal:  J Inherit Metab Dis       Date:  2010-02-02       Impact factor: 4.982

9.  Hyperglycaemia associated with lactic acidaemia in a renal allograft recipient with type I glycogen storage disease.

Authors:  Y T Chen; J I Scheinman
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

10.  Glycogen debranching enzyme deficiency: long-term study of serum enzyme activities and clinical features.

Authors:  R A Coleman; H S Winter; B Wolf; Y T Chen
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.